Back to search

Article

Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCC

2025-06-01

Abstract excerpt

<h4>Purpose</h4> Cisplatin is the gold standard systemic agent for definitive treatment of HNSCC. The purpose of this study was to investigate the role of SPP1 in the progression and metastasis of cisplatin-resistant HNSCC, particularly in the context of NRF2 hyperactivation. <h4>Experimental Design</h4> CDDP resistant HNSCC cell lines stably expressing various shRNA SPP1 constructs were generated. Clonogenic su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5efef809-ce30-5a8f-bcd7-7262f2b2e5fe
DOI
10.1101/2025.05.28.656679
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted suppression of SPP1 inhibits tumor invasion and metastasis in NRF2 hyperactivated cisplatin resistant HNSCCDOI 10.1101/2025.05.28.656679
Select a neighboring publication to make it the new centre.